Atwater Malick LLC Novo Nordisk A S Transaction History

Atwater Malick LLC

$309 Million
Q3 2024

A detailed history of Atwater Malick LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Atwater Malick LLC holds 166,832 shares of NVO stock, worth $18.9 Million. This represents 6.42% of its overall portfolio holdings.

Number of Shares

166,832

Previous 168,500 0.99%

Holding current value

$18.9 Million

Previous $24.1 Million 17.41%

% of portfolio

6.42%

Previous 8.29%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 10, 2024	SELL	$119.07 - $145.42 $198,608 - $242,560	-1,668 Reduced 0.99%	166,832 $19.9 Million
Q2 2024 Jul 17, 2024	SELL	$122.71 - $146.91 $17,670 - $21,155	-144 Reduced 0.09%	168,500 $24.1 Million
Q1 2024 Apr 16, 2024	SELL	$102.11 - $135.92 $166,847 - $222,093	-1,634 Reduced 0.96%	168,644 $21.7 Million
Q4 2023 Jan 11, 2024	SELL	$87.78 - $105.45 $203,122 - $244,011	-2,314 Reduced 1.34%	170,278 $17.6 Million
Q3 2023 Oct 17, 2023	BUY	$90.94 - $199.54 $7.72 Million - $16.9 Million	84,916 Added 96.85%	172,592 $15.7 Million
Q2 2023 Jul 17, 2023	BUY	$155.98 - $172.65 $5,459 - $6,042	35 Added 0.04%	87,676 $14.2 Million
Q1 2023 Apr 19, 2023	SELL	$132.34 - $159.14 $216,375 - $260,193	-1,635 Reduced 1.83%	87,641 $13.9 Million
Q4 2022 Feb 14, 2023	SELL	$102.55 - $135.33 $27,585 - $36,403	-269 Reduced 0.3%	89,276 $12.1 Million
Q3 2022 Nov 02, 2022	BUY	$95.28 - $116.93 $66,505 - $81,617	698 Added 0.79%	89,545 $8.92 Million
Q2 2022 Jul 21, 2022	BUY	$103.24 - $121.81 $72,784 - $85,876	705 Added 0.8%	88,847 $9.9 Million
Q1 2022 Apr 08, 2022	BUY	$93.1 - $112.54 $227,536 - $275,047	2,444 Added 2.85%	88,142 $9.79 Million
Q4 2021 Jan 21, 2022	SELL	$95.88 - $117.08 $79,196 - $96,708	-826 Reduced 0.95%	85,698 $9.6 Million
Q3 2021 Oct 14, 2021	BUY	$84.42 - $106.62 $90,076 - $113,763	1,067 Added 1.25%	86,524 $8.31 Million
Q2 2021 Jul 26, 2021	BUY	$67.66 - $84.76 $267,662 - $335,310	3,956 Added 4.85%	85,457 $7.16 Million
Q1 2021 May 21, 2021	SELL	$67.06 - $75.82 $243,293 - $275,074	-3,628 Reduced 4.26%	81,501 $5.5 Million
Q4 2020 Jan 20, 2021	BUY	$63.89 - $73.8 $88,232 - $101,917	1,381 Added 1.65%	85,129 $5.95 Million
Q3 2020 Oct 13, 2020	BUY	$63.69 - $70.22 $109,355 - $120,567	1,717 Added 2.09%	83,748 $5.82 Million
Q2 2020 Jul 23, 2020	BUY	$58.54 - $67.94 $78,150 - $90,699	1,335 Added 1.65%	82,031 $5.37 Million
Q1 2020 Apr 24, 2020	BUY	$49.46 - $64.78 $66,622 - $87,258	1,347 Added 1.7%	80,696 $4.86 Million
Q4 2019 Jan 07, 2020	BUY	$49.86 - $58.26 $145,940 - $170,527	2,927 Added 3.83%	79,349 $4.59 Million
Q3 2019 Oct 15, 2019	BUY	$47.54 - $53.43 $178,465 - $200,576	3,754 Added 5.17%	76,422 $3.95 Million
Q2 2019 Jul 11, 2019	BUY	$46.79 - $52.47 $142,756 - $160,085	3,051 Added 4.38%	72,668 $3.71 Million
Q1 2019 Apr 12, 2019	BUY	$46.36 - $52.63 $125,589 - $142,574	2,709 Added 4.05%	69,617 $3.64 Million
Q4 2018 Mar 21, 2019	BUY	$41.54 - $47.25 $2.78 Million - $3.16 Million	66,908 New	66,908 $3.08 Million

Others Institutions Holding NVO

# of Institutions

1,963

Shares Held

320M

Call Options Held

5.16M

Put Options Held

4.96M

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $256B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Atwater Malick LLC, based on Form 13F filings with the SEC.

News

Stay updated on Atwater Malick LLC with notifications on news.

Account

Atwater Malick LLC Novo Nordisk A S Transaction History